Bile and excipient interactions directing drug pharmacokinetics in rats

Eur J Pharm Biopharm. 2022 Sep:178:65-68. doi: 10.1016/j.ejpb.2022.07.016. Epub 2022 Aug 3.

Abstract

Bile solubilization plays a major role in the absorption of poorly water-soluble drugs. Excipients used in oral drug formulations impact bile-colloidal properties and their molecular interactions. Polymer-induced changes of bile colloids, e.g., by Eudragit E, reduced the flux of the bile interacting drug Perphenazine whereas bile non-interacting Metoprolol was not impacted. This study corroborates these in vitro findings in rats. Eudragit E significantly reduced systemic availability of Perphenazine but not Metoprolol compared to the oral administrations without polymer. This study confirms the necessity to carefully select polymers for bile interacting drugs whereas non-bile interacting drugs are more robust in terms of excipient choice for formulation. The perspective of bile interaction may introduce interesting biopharmaceutical leverage for better performing oral formulations of tomorrow.

Keywords: Bile; Excipient; In vitro-in vivo correlation; Pharmacokinetics; Rat study.

MeSH terms

  • Animals
  • Excipients*
  • Perphenazine*
  • Pharmaceutical Preparations
  • Polymers
  • Rats
  • Solubility

Substances

  • Excipients
  • Pharmaceutical Preparations
  • Polymers
  • Perphenazine